Darling Ingredients Inc. announced on October 7, 2024, the launch of Nextida™ GC, a new collagen peptide designed to reduce post-meal glucose spikes in healthy individuals. This product is the first in a series of collagen-based solutions with targeted health benefits developed by the company.
Clinical trials conducted by Darling Ingredients' Rousselot brand demonstrated that a 5-gram or 10-gram dose of Nextida GC, taken 30 minutes before a meal, significantly lowered post-meal blood glucose spikes by an average of 42%. This proprietary process unlocks new applications for natural collagen.
The introduction of Nextida GC, with patents pending, positions Darling Ingredients to capitalize on the growing demand for health and wellness products. This innovation is expected to drive higher-margin growth within the Food Ingredients segment by offering a novel solution for glucose moderation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.